Targeting myeloid regulators by paclitaxel-loaded enzymatically degradable nanocups-Reference-Cited by-同舟云学术

Targeting myeloid regulators by paclitaxel-loaded enzymatically degradable nanocups

Published:2018 Issue:37 Volume:10 Page:17990-18000
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Burkert Seth C.¹²³⁴^ORCID,Shurin Galina V.⁵⁶³⁴,White David L.¹²³⁴,He Xiaoyun¹²³⁴,Kapralov Alexandr A.⁷²³⁴^ORCID,Kagan Valerian E.¹²³⁴⁷^ORCID,Shurin Michael R.⁵⁶³⁴⁸,Star Alexander¹²³⁴^ORCID

Affiliation:

1. Department of Chemistry

2. University of Pittsburgh

3. Pittsburgh

4. USA

5. Department of Pathology

6. University of Pittsburgh Medical Center

7. Department of Environmental and Occupational Health

8. Department of Immunology

Abstract

Carbon nanomaterial assisted delivery of paclitaxel to circulating and lymphoid tissue MDSC as proof of concept immunotherapy strategyin vivo.

Funder

Division of Chemistry

Office of Naval Research

National Institute of Environmental Health Sciences

National Cancer Institute

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2018/NR/C8NR04437F

Reference65 articles.

1. Nanocarriers as an emerging platform for cancer therapy

2. Surface modifications for the effective dispersion of carbon nanotubes in solvents and polymers

3. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of nanosystems for melanoma treatment;International Journal of Pharmaceutics;2024-09

2. Research progress of nanomedicine for tumor immunotherapy;Cancer Insight;2024-03-15

3. Role of the bone marrow microenvironment in multiple myeloma treatment using CAR-T therapy;Expert Review of Anticancer Therapy;2023-06-27

4. Nanocarrier functionalization strategies for targeted drug delivery in skin cancer therapy: current progress and upcoming challenges;Expert Opinion on Drug Delivery;2023-06-03

5. Carbon Nanomaterials (CNMs) in Cancer Therapy: A Database of CNM-Based Nanocarrier Systems;Pharmaceutics;2023-05-19